Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

XP (XP) Stock Forecast & Price Target

XP logo
Get the Latest News and Ratings for XP and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for XP and its competitors.

Sign Up

XP Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
6 Buy rating(s)
Hold
4 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$22.17$24.17$24.33$25.00
Forecasted Upside81.99% Upside55.56% Upside32.75% Upside-4.43% Downside
Consensus Rating
Hold
Moderate Buy
Moderate Buy
Moderate Buy

XP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

XP Stock vs. The Competition

TypeXPFinance CompaniesS&P 500
Consensus Rating Score
2.33
2.50
2.51
Consensus RatingHoldHoldModerate Buy
Predicted Upside83.20% Upside18.63% Upside14.52% Upside
News Sentiment Rating
Neutral News

See Recent XP News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/10/2024Bank of America
3 of 5 stars
 DowngradeBuy ➝ Neutral$25.00 ➝ $16.00+19.14%
11/26/2024Morgan Stanley
3 of 5 stars
 Lower TargetEqual Weight ➝ Equal Weight$24.00 ➝ $21.00+30.92%
10/16/2024JPMorgan Chase & Co.
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$28.00 ➝ $29.00+65.15%
7/30/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$22.00 ➝ $19.00+7.83%
7/11/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Batista
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$30.00 ➝ $21.00+15.07%
6/5/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$29.00 ➝ $27.00+42.18%
7/20/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$15.00 ➝ $26.00+9.15%
2/28/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$26.00 ➝ $20.00+61.81%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:05 AM ET.


XP Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for XP is $22.17, with a high forecast of $29.00 and a low forecast of $16.00.

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for XP in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" XP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XP, but not buy additional shares or sell existing shares.

According to analysts, XP's stock has a predicted upside of 81.99% based on their 12-month stock forecasts.

Over the previous 90 days, XP's stock had 1 downgrade by analysts.

XP has been rated by research analysts at Bank of America, JPMorgan Chase & Co., and Morgan Stanley in the past 90 days.

Analysts like XP less than other "finance" companies. The consensus rating score for XP is 2.33 while the average consensus rating score for "finance" companies is 2.50. Learn more on how XP compares to other companies.


This page (NASDAQ:XP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners